Sign in

South African regulator says no major safety concerns from local J&J study

South Africa suspended the rollout of the J&J vaccine in the "implementation study" on Tuesday, after US health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it.

Published on: Apr 14, 2021, 15:49:27 IST
ReutersPosted by
Share
Share via
  • facebook
  • twitter
  • linkedin
Copy link
  • copy link

South Africa's drugs regulator SAHPRA said on Wednesday that it had recently reviewed data from Johnson & Johnson's (J&J) local research study immunising healthcare workers and found no major safety concerns.

J&J’s progress is being watched by experts as its vaccine has the potential to make mass vaccination campaigns much easier. (MINT_PRINT)
J&J’s progress is being watched by experts as its vaccine has the potential to make mass vaccination campaigns much easier. (MINT_PRINT)

SAHPRA added that it was awaiting additional data from J&J and the US Food and Drug Administration.

South Africa suspended the rollout of the J&J vaccine in the "implementation study" on Tuesday, after US health agencies recommended pausing its use because of rare cases of blood clots in six people inoculated with it.

  • Harshit Sabarwal
    ABOUT THE AUTHOR
    Harshit Sabarwal

    Online journalist based in New Delhi. I read about global conflicts and the drug war in Mexico.